197 related articles for article (PubMed ID: 18479962)
21. Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003.
Carr MJ; McCormack GP; Crowley B
J Med Virol; 2004 May; 73(1):131-6. PubMed ID: 15042660
[TBL] [Abstract][Full Text] [Related]
22. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
Levin MJ; DeBiasi RL; Bostik V; Schmid DS
J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
[TBL] [Abstract][Full Text] [Related]
23. Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.
Loparev VN; Rubtcova EN; Bostik V; Govil D; Birch CJ; Druce JD; Schmid DS; Croxson MC
J Virol; 2007 Dec; 81(23):12758-65. PubMed ID: 17898056
[TBL] [Abstract][Full Text] [Related]
24. [Genetic analysis of clinical varicella-zoster virus isolates collected in China].
Gan L; Wang ML; Zhao J; Chen JX
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb; 31(2):189-93. PubMed ID: 21215082
[TBL] [Abstract][Full Text] [Related]
25. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.
Lopez AS; Burnett-Hartman A; Nambiar R; Ritz L; Owens P; Loparev VN; Guris D; Schmid DS
J Infect Dis; 2008 Mar; 197(5):646-53. PubMed ID: 18260757
[TBL] [Abstract][Full Text] [Related]
26. Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method.
Tang YW; Allawi HT; DeLeon-Carnes M; Li H; Day SP; Schmid D
J Clin Virol; 2007 Oct; 40(2):129-34. PubMed ID: 17728179
[TBL] [Abstract][Full Text] [Related]
27. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
Takayama M; Takayama N
J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
[TBL] [Abstract][Full Text] [Related]
28. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
Quinlivan ML; Gershon AA; Steinberg SP; Breuer J
J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408
[TBL] [Abstract][Full Text] [Related]
29. Analysis of repeat units in the R2 region among different Oka varicella-zoster virus vaccine strains and wild-type strains in Germany.
Sauerbrei A; Zell R; Wutzler P
Intervirology; 2007; 50(1):40-4. PubMed ID: 17164556
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of varicella-zoster virus genotypes in Australia characterized by high-resolution melt analysis and ORF22 gene analyses.
Toi CS; Dwyer DE
J Med Microbiol; 2010 Aug; 59(Pt 8):935-940. PubMed ID: 20466839
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
[TBL] [Abstract][Full Text] [Related]
32. New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray.
Sergeev N; Rubtcova E; Chizikov V; Schmid DS; Loparev VN
J Virol Methods; 2006 Sep; 136(1-2):8-16. PubMed ID: 16675033
[TBL] [Abstract][Full Text] [Related]
33. Development of an internally controlled, homogeneous polymerase chain reaction assay for the simultaneous detection and discrimination of herpes simplex virus types 1 and 2 and varicella-zoster virus.
Hobson-Peters J; O'loughlin P; Toye P
Mol Cell Probes; 2007 Feb; 21(1):24-30. PubMed ID: 16963223
[TBL] [Abstract][Full Text] [Related]
34. [Genetic characterization of varicella zoster virus in Jilin province in 2014, China].
Wu QH; Wang S; Cong XL; Zhou JH; Cui AL; Xu WW; Xu ST
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Aug; 50(8):738-42. PubMed ID: 27539529
[TBL] [Abstract][Full Text] [Related]
35. Nationwide distribution of varicella-zoster virus clades in China.
Xu S; Chen M; Zheng H; Wang H; Chen M; Zhou J; Shuang W; Yu P; Ma C; He J; Feng D; Zhen Z; Yan Z; Naiying M; Cui A; Wu Q; Qi M; Li C; Xu X; Xu W
BMC Infect Dis; 2016 Oct; 16(1):542. PubMed ID: 27717328
[TBL] [Abstract][Full Text] [Related]
36. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of wild-type varicella-zoster strains from India and the Oka vaccine strain using a VZV open reading frame - 62 based PCR-RFLP technique.
Kaushik KS; Lahiri KK; Kapila K; Kumar S; Gupta RM; Karade S
Braz J Infect Dis; 2008 Aug; 12(4):313-5. PubMed ID: 19030732
[TBL] [Abstract][Full Text] [Related]
38. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.
Loparev VN; Argaw T; Krause PR; Takayama M; Schmid DS
J Clin Microbiol; 2000 Sep; 38(9):3156-60. PubMed ID: 10970349
[TBL] [Abstract][Full Text] [Related]
39. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
Breuer J; Schmid DS
J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
[TBL] [Abstract][Full Text] [Related]
40. Novel approach for genotyping varicella-zoster virus strains from Germany.
Schmidt-Chanasit J; Stürmer M; Hahn A; Schäd SG; Gross G; Ulrich RG; Heckel G; Doerr HW
J Clin Microbiol; 2007 Nov; 45(11):3540-5. PubMed ID: 17855572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
